Crossmark

Disease control in patients with ankylosing spondylitis in real clinical practice in Spain: Results of the MIDAS study

Crossref DOI link: https://doi.org/10.1016/j.reuma.2022.01.004

Published Print: 2023-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

de Miguel, Eugenio http://orcid.org/0000-0001-5146-1964
Fernández-Carballido, Cristina http://orcid.org/0000-0002-0910-4944
Gratacós, Jordi http://orcid.org/0000-0003-4007-4103
Pablos, José L. http://orcid.org/0000-0001-7229-6005
Juanola, Xavier http://orcid.org/0000-0001-5998-6300
Ariza, Rafael http://orcid.org/0000-0001-9937-0252
Terradas-Montana, Pau http://orcid.org/0000-0002-0054-9293
Sanabra, Cristina http://orcid.org/0000-0003-1046-0265
Sastré, Carlos http://orcid.org/0000-0002-1577-7838
Funding

Funding for this research was provided by:

Novartis Farmacéutica
License Information

Text and Data Mining valid from 2023-02-01

stm-asf valid from 2023-02-01

stm-asf valid from 2023-02-01

stm-asf valid from 2023-02-01

stm-asf valid from 2023-02-01

stm-asf valid from 2023-02-01
More Information

This article is maintained by: Elsevier

Article Title: Disease control in patients with ankylosing spondylitis in real clinical practice in Spain: Results of the MIDAS study

Journal Title: Reumatología Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reuma.2022.01.004

Content Type: article

Copyright: © 2022 Published by Elsevier España, S.L.U.